National Cancer Institute. Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma. Bethesda, MD: National Library of Medicine; 2007. http://clinicaltrials.gov/ct/show/NCT00567567. NLM: Identifier NCT00567567.
2.
YuALGilmanALOzkaynakMF. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med. 2010;363(14):1324-1334.
3.
AdamsGAShochatSJSmithEI. Thoracic neuroblastoma: a Pediatric Oncology Group study. J Pediatr Surg. 1993;28(3):372-377; discussion 377-378.